eli lilly retatrutide phase 3 trial TRIUMPH-4 Results: 28.7% Weight Loss & What It Means for the Peptide Industry retatrutide clinical trial benefits New

Tom-Castro XM, Rodriguez-Arrastia M, Cardona D, Rueda-Ruzafa L, Molina-Torres G, Roman P

Curious if a GLP1 medication could help you reach your health goals

Holistic Health Transformation Peptide Therapy and Weight Loss Programs Peptides support your body at a cellular level, optimizing recovery, lean muscle support, fat metabolism, and inflammation reduction

This study found that people taking GLP-1 medications had a higher chance of developing nonscarring hair loss, says Adam Friedman, MD, a study coauthor and chair of the dermatology department at George Washington University in Washington, DC

In the Phase 3 ESSENCE trial, MASH resolved without any worsening fibrosis in around 63% of patients on semaglutide versus 34% on placebo